We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Sysmex America Exhibits New Products, Automation and Quality Solutions

By LabMedica International staff writers
Posted on 06 Aug 2019
Print article
Image: The PS-10, designed for complex laboratory-developed tests and routine flow cytometry applications (Photo courtesy of Sysmex America).
Image: The PS-10, designed for complex laboratory-developed tests and routine flow cytometry applications (Photo courtesy of Sysmex America).
Sysmex America, Inc. (Lincolnshire, IL, USA), a diagnostic solutions company offering hematology, urinalysis and flow cytometry testing technology, exhibited its expanded line of products and services at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo.

At AACC 2019, Sysmex demonstrated its products, processes, automation, quality, and best practices in clinical laboratory management. Sysmex showcased its highly automated and flexible PS-10, which is designed for complex laboratory-developed tests and routine flow cytometry applications, providing clinical laboratories with a new level of workflow efficiency and confidence in accurate results. The PS-10 automates sample preparation, alleviating primary operational bottlenecks in busy clinical flow laboratories, as well as eliminating variability between operators. The PS-10 also offers standardization for antibody cocktailing and reduces the amount of manual transferring of samples performed by laboratory staff.

The company also demonstrated its complete blood count (CBC) analyzer, the XN-20, a complementary system to the XN-10, but with an additional analysis channel. The White Precursor Cell (WPC) channel, which provides improved differentiation of abnormal WBC populations, adds further efficiency for laboratories. Also on display at the tradeshow was the UN-2000, Sysmex’s first fully automated urine particle counter and digital imaging system that provides laboratories with a highly standardized and efficient process for urine sediment analysis, one with less manual intervention and greater accuracy. Using fluorescence flow cytometry, the UN-2000 reduces time consuming hands-on review, delivering highly accurate particle quantitation and differentiation through walk-away loading, standardized criteria with high reproducibility, quantitative measurement and automated validation helping the review of the technologist.

In software solutions, Sysmex demonstrated its quality management system BeyondCare Quality Monitor for Hematology (BCQMh), which streamlines the end-to-end process of running controls and reviewing results, leading to improved analyzer productivity. The web-based quality control and calibration verification management program uses evidence-based quality control. Sysmex also highlighted it powerful software solution Caresphere Laboratory Management (LM) for monitoring quality, productivity and efficiency data, enabling labs to optimize their performance. Bringing together crucial elements such as turnaround times, rerun ratios, analyzer conditions and performance metrics, Caresphere LM provides at-a-glance metrics and status updates designed to give labs the information they need without having to search through multiple software systems. Whether managing one site or many, accessing statistics and calibration data is made simple with Caresphere LM.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
PSA Test
Humasis PSA Card
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: The researchers detected genomic alterations from plasma cfDNA (Photo courtesy of 123RF)

Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors

Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.